Inventor · disambiguated record
Rhian Sara Holvey
Also filed as: HOLVEY RHIAN SARA
7 granted patents·4 pending applications·25 citations·filing 2016–2024
81Inventor score
Top patents by PatentIndex Score
11 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0292US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0392US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0485US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 0584US12077526B2Isoindolinone inhibitors of the MDM2-P53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2023·Granted Sep 3, 2024·1 cites·22 claims
- 0683US11466016B2Pharmaceutical compoundsOTSUKA PHARMA CO LTD·Filed 2019·Granted Oct 11, 2022·2 cites·27 claims
- 0782US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0870US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 0970US2025074900A1Isoindolinone inhibitors of the mdm2-p53 interaction and process for making themASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1067US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1150US2023348495A1A compound having inhibitory activity against kras g12d mutationTAIHO PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rhian Sara Holvey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →